This is a Study to Evaluate the Safety, Tolerability, PK and PD of IV Administered ABL301 in Healthy Adult Participants
Clinical trial NCT05756920 · COMPLETED
Trial details
- NCT number
- NCT05756920
- Sponsor
- ABL Bio, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-31
- Primary completion
- 2025-04-30
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.